USFDA conducts inspection at Zydus Lifesciences’ API site in Ahmedabad

23 Dec 2023 Evaluate

United States Food and Drug Administration (USFDA) has conducted an inspection at Zydus Lifesciences’ API site situated at Changodar, Ahmedabad. This PAI-cum-GMP USFDA inspection was conducted from December 14 to December 22, 2023. The inspection closed with 6 observations.

There were no Data Integrity related observations. There are no repeat observations from the previous inspection. There are 4 DMFs of this site under approval with the USFDA. The company will closely work with the USFDA to address the observations. 

Zydus Lifesciences (formerly known as Cadila Healthcare) is an India-based pharmaceutical company. 


Zydus Lifesciences Share Price

1050.35 -8.20 (-0.77%)
28-May-2024 15:49 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1464.85
Dr. Reddys Lab 5955.65
Cipla 1477.15
Zydus Lifesciences 1050.35
Lupin 1603.55
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.